SAG and lung cancer: The endogenous binding of these E2–E3 pairs was further confirmed in two lung cancer cell lines under physiological unstressed conditions in a pull-down assay using antibody against either SAG or RBX1 (Figs 4B and S4B) or antibodies against each of four E2s (Figs 4C and S4C).